Novel Bacteriophages Capable of Disrupting Biofilms From Clinical Strains of Aeromonas hydrophila
Author(s) -
Mwila Kabwe,
Teagan L. Brown,
Lachlan B. M. Speirs,
Heng Ku,
Michael Leach,
Hiu Tat Chan,
Steve Petrovski,
Peter Lock,
Joseph Tucci
Publication year - 2020
Publication title -
frontiers in microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.701
H-Index - 135
ISSN - 1664-302X
DOI - 10.3389/fmicb.2020.00194
Subject(s) - aeromonas hydrophila , lytic cycle , biology , bacteriophage , microbiology and biotechnology , biofilm , aeromonas , organism , bacteria , antibiotic resistance , pathogenic bacteria , antibiotics , isolation (microbiology) , virus , virology , gene , genetics , escherichia coli
The increase in global warming has favored growth of a range of opportunistic environmental bacteria and allowed some of these to become more pathogenic to humans. Aeromonas hydrophila is one such organism. Surviving in moist conditions in temperate climates, these bacteria have been associated with a range of diseases in humans, and in systemic infections can cause mortality in up to 46% of cases. Their capacity to form biofilms, carry antibiotic resistance mechanisms, and survive disinfection, has meant that they are not easily treated with traditional methods. Bacteriophage offer a possible alternative approach for controlling their growth. This study is the first to report the isolation and characterization of bacteriophages lytic against clinical strains of A. hydrophila which carry intrinsic antibiotic resistance genes. Functionally, these novel bacteriophages were shown to be capable of disrupting biofilms caused by clinical isolates of A. hydrophila. The potential exists for these to be tested in clinical and environmental settings.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom